Relnac Plus IM Injection

Diclofenac Sodium + Lidocaine Hydrochloride Indications The injection contains Diclofenac Sodium that is used to relief all grades of pain and inflammation in a wide range of conditions including: The injection also contains Lidocaine which acts as a local anaesthetic. Therefore the possibility of pain at the injection site, which is most likely to occur […]

Relnac Gel

Diclofenac Sodium Indications Rheumatology: Inflammatory and degenerative forms of rheumatism, chronic involutive, polyarthritis, ankylosing spondylarthritis, osteoarthritis, spondylarthroses, acute gout, peri-articular rheumatic disorders. Surgery and Traumatology: Sprain, bruises, dislocations, fractures, softtissue injuries, surgical interventions. Obstetrics and Gynecology: Primary dysmenorrhoea, episiotomy, adnexitis, endometritis, parametritis, salpingitis, and mastitis. Otorhinolaryngology: As pre-operative medication for the prevention of pain, inflammation, […]

Reclevus Met Tablet

Vildagliptin + Metformin Hydrochloride Indications This tablet is indicated as an adjunct to diet and exercises to improve glycaemic control in patients with type 2 diabetes mellitus whose diabetes is not adequately controlled on Metformin Hydrochloride or Vildagliptin alone or who are already treated with the combination of Vildagliptin and Metformin Hydrochloride, as separate tablets. […]

Reclevus Tablet

Vildagliptin Indications Reclevus is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus as monotherapy and in dual combination with Metformin, a Sulphonylurea, a Thiazolidinedione, or Insulin when diet, exercise and a single antidiabetic agent do not result in adequate glycemic control. Pharmacology Vildagliptin is […]

Rabefour Capsule (Enteric Coated)

Rabeprazole Sodium Indications Rabefour Gastro-resistant tablets are indicated for the treatment of: Pharmacology Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor. […]

Quetinil Tablet

Quetiapine Fumarate Indications Quetinil is indicated for the treatment of Acute and chronic psychoses, including schizophrenia, Bipolar Disorder including: treatment of manic episodes satisfying DSM-IV criteria for mania associated with bipolar  disorder, treatment of depressive episodes associated with bipolar disorder, maintenance treatment of bipolar I disorder, in combination with a mood stabilizer, for the prevention […]

Pregabid Capsule

Pregabalin Indications Pregabid is indicated for: Pregabid CR tablet is indicated for: Pharmacology Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system […]

Povimax Mouthwash

Povidone Iodine Indications Cream or ointment:Therapeutically: As an adjunct to systemic therapy in the following indications- Prophylactically: Solution: Gargle & Mouthwash: It is a pleasantly flavoured solution which is used: Surgical Scrub: It is a golden surfactant solution, forms rich, golden lather which is used: As an antiseptic skin cleanser for preoperative and postoperative scrubbing […]

Plator Plus Tablet

Clopidogrel + Aspirin Indications Acute Coronary Syndrome (ACS): It is indicated to reduce the rate of Myocardial Infarction (MI) and Stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation Myocardial Infarction (NSTEMI)] and acute ST-segment elevation ACS [ST-elevation Myocardial Infarction (STEMI)]. Recent MI, recent Stroke, or established Peripheral Arterial Disease: In patients with established […]

Plator Tablet

Clopidogrel Bisulphate Indications Acute Coronary Syndrome (ACS): It is indicated to reduce the rate of myocardial infarction (MI) and stroke in patients with non-ST-segment elevation ACS [unstable angina (UA)/non-ST-elevation myocardial infarction (NSTEMI)]. It is indicated to reduce the rate of myocardial infarction and stroke in patients with acute ST-elevation myocardial infarction (STEMI). Recent MI, recent […]